Valuation: GC Genome Corporation

Market Cap 105B 70.48M 61.81M 57.25M 52.68M 99.64M 6.75B 102M 682M 268M 3.31B 265M 259M 11.44B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 45.85M 30.7K 26.93K 24.94K 22.95K 43.4K 2.94M 44.25K 297K 117K 1.44M 115K 113K 4.98M EV / Sales 2026 *
1.18x
EV / Sales 2027 * 0.75x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day-6.71%
1 week-8.44%
Current month-9.46%
1 month-16.51%
3 months-40.51%
6 months-32.98%
Current year-34.75%
1 week 4,300
Extreme 4300
4,900
1 month 4,225
Extreme 4225
5,710
Current year 4,225
Extreme 4225
9,520
1 year 4,225
Extreme 4225
9,520
3 years 4,225
Extreme 4225
15,180
5 years 4,225
Extreme 4225
15,180
10 years 4,225
Extreme 4225
15,180
Manager TitleAgeSince
Chief Executive Officer 57 2020-03-25
Director of Finance/CFO 50 2025-03-26
Comptroller/Controller/Auditor 45 2024-03-28
Director TitleAgeSince
Director/Board Member 57 2023-03-29
Date Insider Type Main position Quantity % Market Cap.
25-06-16Free

Chief Executive Officer

169,285 -
25-06-16Free 138,250 -
Change 5-day change 1-year change 3-year change Capi.($)
-6.71%-8.44%-51.74% - 75.13M
+1.09%-3.84%+70.10%+437.29% 38.66B
-0.05%-2.71%+10.84%+30.67% 22.7B
+1.31%-2.88%-22.09%-40.55% 7.3B
-3.49%-8.14%+14.11%+106.96% 5.16B
+1.91%+2.32%+17.90%+46.50% 2.97B
-2.73%-7.32%-22.66%+818.71% 1.95B
-1.17%+4.12%+33.47%-21.11% 1.84B
0.00%-6.93%+94.35%-18.81% 1.84B
+4.87%+3.19%+27.97%+4.06% 1.75B
Average -0.48%-1.98%+17.22%+151.52% 8.42B
Weighted average by Cap. +0.47%-2.72%+37.47%+232.00%

Financials

2026 *2027 *
Net sales 39B 26.12M 22.91M 21.22M 19.52M 36.92M 2.5B 37.64M 253M 99.17M 1.23B 98.07M 95.92M 4.24B 48.8B 32.68M 28.66M 26.55M 24.43M 46.2M 3.13B 47.1M 316M 124M 1.54B 123M 120M 5.3B
Net income - -
Net Debt -59.4B -39.78M -34.89M -32.31M -29.73M -56.24M -3.81B -57.33M -385M -151M -1.87B -149M -146M -6.46B -68.8B -46.07M -40.41M -37.43M -34.44M -65.13M -4.41B -66.4M -446M -175M -2.17B -173M -169M -7.48B
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
26-07-13 ₩4,450.00 -6.71% 63,035
26-07-10 ₩4,770.00 +5.41% 56,967
26-07-09 ₩4,525.00 -1.95% 151,494
26-07-08 ₩4,615.00 -3.35% 84,948
26-07-07 ₩4,775.00 -1.75% 117,949

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock